SCHEMBL1279581

SCHEMBL1279581

COC(O)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LAP3 P28838 1/20 0.50
TRPA1 O75762 2/20 0.48
TAAR1 Q96RJ0 4/20 0.46
SLC6A2 P23975 2/20 0.46
SIGMAR1 Q99720 2/20 0.46
MAOA P21397 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
CYP2A6 P11509 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
CYP1A2 P05177 1/20 0.45
EPHX1 P07099 1/20 0.44
SLC18A2 Q05940 1/20 0.43
CYP2D6 P10635 1/20 0.43
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
SRR Q9GZT4 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7268862 1.00 LAP3 (0.50) LAP3TRPA1TAAR1SLC6A2SIGMAR1
SCHEMBL11491833 0.81 CYP1A2 (0.48) LAP3TRPA1TAAR1SLC6A2SIGMAR1
SCHEMBL10589698 0.81 MDM2 (0.48) LAP3TRPA1TAAR1SLC6A2SIGMAR1
Citric Acid SCHEMBL17164704 0.80 LMNA (0.49) LAP3CYP1A2CYP2D6
SCHEMBL6204603 0.80 AGXT (0.40) TAAR1SLC6A4CYP2A6CYP1A2PPARG
Methoxymethane SCHEMBL12231182 0.79 TAAR1 (0.54) LAP3TRPA1TAAR1SLC6A2SIGMAR1
SCHEMBL20828503 0.78 LOXL2 (0.46) TAAR1SLC6A2SLC6A4
SCHEMBL29226038 0.78 LAP3 (0.33) LAP3SLC6A4
SCHEMBL6204427 0.78 LDHA (0.58) SLC6A4CYP1A2CYP2D6
SCHEMBL28936112 0.78 CYP3A4 (0.50) SLC6A2SLC6A4SLC6A3CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116289210-B Bath towel with strong water absorbability and preparation method thereof 江苏南星家纺有限公司 2024-03-19 CN claimed
CN-116289210-A Bath towel with strong water absorbability and preparation method thereof 江苏南星家纺有限公司 2023-06-23 CN claimed
US-9616459-B1 Polymeric coatings for fortification of visible, infrared, and laser optical devices LOCKHEED MARTIN CORPORATION (US) 2017-04-11 US claimed
US-6989052-B1 Phase change ink printing process XEROX CORPORATION (US) 2006-01-24 US claimed
US-20060004123-A1 PHASE CHANGE INK PRINTING PROCESS XEROX CORPORATION 2006-01-05 US claimed
WO-1998041492-A1 METHOD FOR PRODUCING AROMATIC ALCOHOLS AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) 1998-09-24 WO claimed
WO-1998014546-A1 LAUNDRY DETERGENT COMPOSITION COMPRISING HYDROPHOBIC SOLVENT AND HYDROPHILIC SOLVENT THE PROCTER & GAMBLE COMPANY (US) 1998-04-09 WO claimed
EP-0834550-A1 Laundry detergent compositions THE PROCTER & GAMBLE COMPANY (US) 1998-04-08 EP claimed
US-12577465-B2 Method for producing semiconductor treatment liquid and method for producing semiconductor element TOKUYAMA CORPORATION (JP) 2026-03-17 US disclosed
US-12564879-B2 Copper paste for joining, method for manufacturing joined body, and joined body RESONAC CORPORATION (JP) 2026-03-03 US disclosed
CN-119285445-A Preparation method of aromatic alcohol 安徽泰格生物科技有限公司 2025-01-10 CN disclosed
US-20240181575-A1 COPPER PASTE FOR FORMING SINTERED COPPER PILLARS AND METHOD FOR PRODUCING BONDED BODY RESONAC CORPORATION (JP) 2024-06-06 US disclosed
WO-2024063107-A1 RELEASE AGENT, SOLVENT FOR SEMICONDUCTOR, TREATMENT LIQUID FOR SEMICONDUCTOR, RELEASE METHOD, AND SEMICONDUCTOR DEVICE MANUFACTURING METHOD 株式会社トクヤマ 2024-03-28 WO disclosed
CN-116289210-B Bath towel with strong water absorbability and preparation method thereof 江苏南星家纺有限公司 2024-03-19 CN disclosed
EP-0256888-A1 Benzothiazepine vasodilators having aralkyl substitution McNeilab, Inc. (US) 1988-02-24 EP disclosed
US-4698340-A TREATMENT OF CEREBROVASCULAR DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-10-06 US disclosed
US-4609765-A TITANIUM SILICALITE CATALYST ANIC, S.P.A. (IT) 1986-09-02 US disclosed
EP-0169712-A2 New pyrimidine derivatives, processes for preparation thereof and composition containing the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-01-29 EP disclosed
EP-0102097-B1 PROCESS FOR OXIDISING VINYLBENZENE COMPOUNDS TO BETA-PHENYLALDEHYDES ANIC S.p.A. (IT) 1986-01-02 EP disclosed
EP-0102097-A2 Process for oxidising vinylbenzene compounds to beta-phenylaldehydes ANIC S.p.A. (IT) 1984-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577465-B2 Method for producing semiconductor treatment liquid and method for producing semiconductor element PPA1, HAO2, SEM1 LAP3 4520/4885TRPA1 663/4885TAAR1 2395/4885
US-12564879-B2 Copper paste for joining, method for manufacturing joined body, and joined body DCX, DNAJA2, DNAJA1 LAP3 4117/4885TRPA1 1773/4885TAAR1 3783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.